Total Payments
$1,253
2020 Payments
$285.84
Companies
10
Transactions
20
Medicare Patients
1,812
Medicare Billing
$157,862
Payment Breakdown by Category
Food & Beverage$1,253 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,253 | 20 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $316.28 | 4 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $241.44 | 6 | $0 (2020) |
| Janssen Pharmaceuticals, Inc | $152.07 | 2 | $0 (2020) |
| La Jolla Pharmaceutical Company | $121.69 | 2 | $0 (2020) |
| Valeant Pharmaceuticals North America LLC | $99.39 | 1 | $0 (2017) |
| The Medicines Company | $93.74 | 1 | $0 (2017) |
| BTG INTERNATIONAL, INC. | $89.32 | 1 | $0 (2020) |
| Philips Electronics North America Corporation | $79.50 | 1 | $0 (2018) |
| PFIZER INC. | $47.75 | 1 | $0 (2019) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $12.23 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2020 | $285.84 | 7 | BTG INTERNATIONAL, INC. ($89.32) |
| 2019 | $327.34 | 6 | AstraZeneca Pharmaceuticals LP ($128.78) |
| 2018 | $167.27 | 2 | AstraZeneca Pharmaceuticals LP ($87.77) |
| 2017 | $472.96 | 5 | E.R. Squibb & Sons, L.L.C. ($156.54) |
All Payment Transactions
20 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/10/2020 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $12.94 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/15/2020 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $11.95 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/10/2020 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $12.23 | General |
| Category: GASTROENTEROLOGY | ||||||
| 04/08/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $28.78 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/12/2020 | BTG INTERNATIONAL, INC. | CROFAB (Drug) | Food and Beverage | Cash or cash equivalent | $89.32 | General |
| Category: ANTI-VENOM | ||||||
| 02/13/2020 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $52.06 | General |
| Category: Cardiovascular | ||||||
| 01/09/2020 | La Jolla Pharmaceutical Company | GIAPREZA (Drug) | Food and Beverage | In-kind items and services | $78.56 | General |
| Category: EMERGENT HYPOTENSION | ||||||
| 10/02/2019 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $12.94 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/12/2019 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $105.94 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/08/2019 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $47.75 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 07/11/2019 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $107.68 | General |
| Category: Cardiovascular | ||||||
| 06/07/2019 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $9.90 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/10/2019 | La Jolla Pharmaceutical Company | GIAPREZA (Drug) | Food and Beverage | In-kind items and services | $43.13 | General |
| Category: GIAPREZA | ||||||
| 03/08/2018 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $87.77 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/08/2018 | Philips Electronics North America Corporation | IGT_D Peripheral (Device) | Food and Beverage | Cash or cash equivalent | $79.50 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/14/2017 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $123.29 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/11/2017 | Valeant Pharmaceuticals North America LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $99.39 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/13/2017 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $58.49 | General |
| Category: Cardiovascular | ||||||
| 04/12/2017 | The Medicines Company | MINOCIN IV (Drug), ORBACTIV | Food and Beverage | In-kind items and services | $93.74 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 03/08/2017 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $98.05 | General |
| Category: Cardiovascular | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 241 | 245 | $244,611 | $20,630 |
| 2022 | 4 | 531 | 541 | $470,368 | $44,238 |
| 2021 | 4 | 688 | 720 | $604,483 | $61,920 |
| 2020 | 4 | 352 | 359 | $276,871 | $31,075 |
Total Patients
1,812
Total Services
1,865
Medicare Billing
$157,862
Procedure Codes
16
All Medicare Procedures & Services
16 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99285 | Emergency department visit with high level of medical decision making | Facility | 2023 | 111 | 111 | $167,036 | $14,199 | 8.5% |
| 99284 | Emergency department visit with moderate level of medical decision making | Facility | 2023 | 61 | 62 | $65,584 | $5,527 | 8.4% |
| 99283 | Emergency department visit with low level of medical decision making | Facility | 2023 | 11 | 11 | $7,111 | $545.70 | 7.7% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 58 | 61 | $4,880 | $357.84 | 7.3% |
| 99285 | Emergency department visit for life threatening or functioning severity | Facility | 2022 | 238 | 243 | $352,896 | $33,872 | 9.6% |
| 99284 | Emergency department visit for problem of high severity | Facility | 2022 | 72 | 72 | $74,982 | $6,735 | 9.0% |
| 99283 | Emergency department visit for problem of moderate severity | Facility | 2022 | 44 | 44 | $28,222 | $2,497 | 8.8% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2022 | 177 | 182 | $14,268 | $1,135 | 8.0% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2021 | 353 | 360 | $495,048 | $51,701 | 10.4% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2021 | 71 | 78 | $74,837 | $7,194 | 9.6% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Facility | 2021 | 239 | 257 | $19,729 | $1,635 | 8.3% |
| 99283 | Emergency department visit, moderately severe problem | Facility | 2021 | 25 | 25 | $14,869 | $1,389 | 9.3% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2020 | 177 | 181 | $230,373 | $26,207 | 11.4% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2020 | 31 | 31 | $26,505 | $3,024 | 11.4% |
| 99283 | Emergency department visit, moderately severe problem | Facility | 2020 | 18 | 18 | $10,191 | $968.24 | 9.5% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Facility | 2020 | 126 | 129 | $9,802 | $875.24 | 8.9% |
About Dr. Melissa Harris, D.O
Dr. Melissa Harris, D.O is a Emergency Medicine healthcare provider based in Seminole, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/05/2016. The National Provider Identifier (NPI) number assigned to this provider is 1710339536.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Melissa Harris, D.O has received a total of $1,253 in payments from pharmaceutical and medical device companies, with $285.84 received in 2020. These payments were reported across 20 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($1,253).
As a Medicare-enrolled provider, Harris has provided services to 1,812 Medicare beneficiaries, totaling 1,865 services with total Medicare billing of $157,862. Data is available for 4 years (2020–2023), covering 16 distinct procedure/service records.
Ad
Practice Information
- Specialty Emergency Medicine
- Location Seminole, OK
- Active Since 07/05/2016
- Last Updated 07/11/2018
- Taxonomy Code 207P00000X
- Entity Type Individual
- NPI Number 1710339536
Products in Payments
- ELIQUIS (Drug) $364.03
- XARELTO (Drug) $152.07
- LOKELMA (Drug) $143.77
- GIAPREZA (Drug) $121.69
- XIFAXAN (Drug) $99.39
- BRILINTA (Drug) $97.67
- MINOCIN IV (Drug) $93.74
- CROFAB (Drug) $89.32
- IGT_D Peripheral (Device) $79.50
- RELISTOR (Drug) $12.23
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.